Your browser doesn't support javascript.
loading
Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.
Webb, Joanne; Mount, Julie; von Arx, Lill-Brith; Rachman, Jonathan; Spanopoulos, Dionysis; Wood, Robert; Tritton, Theo; Massey, Olivia; Idris, Iskandar.
Afiliação
  • Webb J; Eli Lilly and Company, Basingstoke, UK.
  • Mount J; Eli Lilly and Company, Basingstoke, UK.
  • von Arx LB; Eli Lilly and Company, Herlev, Denmark.
  • Rachman J; Eli Lilly and Company, Basingstoke, UK.
  • Spanopoulos D; Eli Lilly and Company, Basingstoke, UK.
  • Wood R; Adelphi Real World, Bollington, UK.
  • Tritton T; Adelphi Real World, Bollington, UK.
  • Massey O; Adelphi Real World, Bollington, UK.
  • Idris I; University of Nottingham, Nottingham, UK.
Diabetes Obes Metab ; 24(2): 289-295, 2022 02.
Article em En | MEDLINE | ID: mdl-34668637
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article